Enlivex Therapeutics Ltd

NASDAQ:ENLV 11:57:29 AM EDT

1.65

-0.11 (-6.25%)

Enlivex Therapeutics Ltd Stock, NASDAQ:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618

Israel

Phone: +972.8.662.3301

Number of Employees: 77

http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.